Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
about
Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model.Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccineImmunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccinationEffects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine.The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.Consistency of HLA associations between two independent measles vaccine cohorts: a replication studyIndependence of measles-specific humoral and cellular immune responses to vaccinationReplication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremesInhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy.Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses.Variability in Humoral Immunity to Measles Vaccine: New Developments.Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity.Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens.The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.Immunogenicity of novel mumps vaccine candidates generated by genetic modification.Evaluating measles vaccines: can we assess cellular immunity?Immunoglobulin GM and KM genes and measles vaccine-induced humoral immunity.Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination.Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells.Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran.
P2860
Q30496489-C76281DF-0B16-4A1D-8DD1-FE4FC4D2D1DAQ34345266-E2A05BC5-2BBA-4ECA-8C4E-2ADE3F864E80Q35051541-FFC193C1-5180-416F-A16B-38B6C3B94CA4Q35096934-06F60DFE-55C0-4DCD-8CB8-9AA854D8E16FQ35232801-32E864BC-27E5-46FD-8945-F69C99091866Q35318219-E7882378-3C62-4F22-A912-AC8A9C42ADB9Q35613190-5B6A9642-4285-4FB0-BCC5-9C4ACE20BEB4Q35623608-07AF6412-B700-45F0-A2AD-A3AE32AA413CQ35784185-4BE6A22A-F558-475E-AF54-F3B4F573BFBCQ35785581-A085CE60-E710-4A90-8AC7-62CC8666C873Q35918575-C8B88A5B-936A-4E90-A8B1-0B76FBD67A8CQ36010709-289D98EB-19DF-449A-BE02-574513D1194EQ36108892-FAE4B7B8-FDFA-4438-B7EA-96E055907EF4Q36197585-5CF7ABA2-067B-4B21-815E-8CA7FA231934Q36269765-7581D812-3F71-421F-9B65-DAA7EF903640Q36373260-D63C793D-43C5-4B1D-A9D5-5257191E4F48Q36816196-FE0D153B-0A5D-4A4F-9C33-896BA0E8455FQ37520259-5B8ADFA9-CCFF-4A13-B421-510245F9DF62Q37583889-F34A12E9-5665-4C87-97F3-6BDCD8EC887FQ37616442-68A635B9-F4D8-45A4-B51E-9D46BEAE5113Q37644086-E6A0E49F-B473-4DE0-88B8-800211CDCEF5Q38036683-D9969449-454E-492B-86C9-E1E6C9D4A8F7Q38919962-AB68197F-6D49-4D53-A18D-7C0B0EF07BC0Q38945450-E9358A29-7328-4D26-A7BC-95E3C3B90D69Q39221090-3BE693DA-EA3D-48F0-8046-8747ACE952EAQ40517930-778516FF-2BA6-40DE-A323-9FE351AFC85E
P2860
Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Development of a novel efficie ...... ay for measles virus immunity.
@en
type
label
Development of a novel efficie ...... ay for measles virus immunity.
@en
prefLabel
Development of a novel efficie ...... ay for measles virus immunity.
@en
P2860
P50
P356
P1476
Development of a novel efficie ...... ay for measles virus immunity.
@en
P2860
P304
P356
10.1128/CVI.00008-08
P577
2008-05-07T00:00:00Z